Quan Capital
Home
About Us
BackgroundInvestment StrategyTeam
Portfolio
News
Contact
EN|中文
Investor Login

We are Company Builders

Identifying, incubating and growing future industry leaders in life sciences

We are Industry Veterans

Capturing evolving healthcare trends and emerging cutting-edge innovations

We are Preferred Partners

Connecting companies with extensive network and resources globally and in China

16 Nov 2026Windward Bio Announces Closing of $251.2 Million Initial Public Offering and Concurrent Private Placement, Including Full Exercise of Underwriters' Option to Purchase Additional Shares Concurrent Private Placement, Including Full Exercise of Underwriters’ Option to Purchase Additional SharesRead more12 Nov 2026Windward Bio Announces Pricing of Initial Public OfferingRead more5 Nov 2026HY3003, Co-developed by iCarbonX Pharmaceutical, Cleared for U.S. Clinical TrialRead more
All news
Quan Capitalinfo@quancapital.com
China

899 Halei Road, Building B, 4/F, Pudong New Area, Shanghai 201203, P.R. China

Phone: +86 21 6163 2598

Fax: +86 21 6163 2570

© Quan Capital. All rights reserved. Website development. 沪ICP备18031693号-1